Publication: 2350

Publication: 2350

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720

URL

Google Scholar

Citation:: J Clin Oncol vol 26 (30) 4934-4939

Meeting Instance:: ASCO 2008
Year:: 2008
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 86

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:
Grants:: CA31946, CA33601, )CA31983, CA02599, CA77658, CA35279, CA03927, CA47577, CA32291, CA41287

Corr. Author:: Baer
Authors:: Maria R. Baer Stephen L. George Michael A. Caligiuri Ben L. Sanford Sandra M. Bothun Krzysztof Mrózek Jonathan E. Kolitz Bayard L. Powell Joseph R. Moore Richard M. Stone John Anastasi Clara D. Bloomfield Richard A. Larson

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-10201, CALGB-10502, CALGB-10503, CALGB-10603, CALGB-19808, CALGB-8525, CALGB-8923, CALGB-9022, CALGB-9222, CALGB-9420, CALGB-9621, CALGB-9720
Phases:: 1, 1/2, 2, 3

Keywords: